Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2006-03-22
2010-02-02
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S059000, C536S055100, C536S055200, C536S112000
Reexamination Certificate
active
07655639
ABSTRACT:
The present invention is a minimally invasive clinical method for closing hernias and other abnormal openings existing within the body; and is a unique alternative to conventional surgery and routine surgical techniques for correcting such medical defects. The clinical applications for the present methodology can be used for the in-vivo closure of small sized lumens and voids which naturally occur and exist internally within the soft connective tissue and organs of the living human body; can be employed to advantage for the closure of hernias generally; and is focused upon the closure of umbilical hernias specifically.
REFERENCES:
patent: 7166570 (2007-01-01), Hunter et al.
patent: 2004/0092970 (2004-05-01), Xavier
Chidren's Medical Center Corporation
Jiang Shaojia Anna
Nixon & Peabody LLP
Olson Eric S
LandOfFree
Minimally invasive clinical treatment method for closure of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Minimally invasive clinical treatment method for closure of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Minimally invasive clinical treatment method for closure of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4197367